These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17375078)

  • 1. Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.
    Russell JC; Proctor SD
    Br J Pharmacol; 2007 May; 151(2):216-25. PubMed ID: 17375078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats.
    Russell JC; Proctor SD; Kelly SE; Brindley DN
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1078-87. PubMed ID: 18413677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat.
    Proctor SD; Kelly SE; Stanhope KL; Havel PJ; Russell JC
    Diabetes Obes Metab; 2007 Jan; 9(1):87-95. PubMed ID: 17199723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome.
    Russell JC; Kelly SE; Diane A; Wang Y; Mangat R; Novak S; Vine DF; Proctor SD
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G507-16. PubMed ID: 20508159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular wall dysfunction in JCR:LA-cp rats: effects of age and insulin resistance.
    O'brien SF; Russell JC; Davidge ST
    Am J Physiol; 1999 Nov; 277(5):C987-93. PubMed ID: 10564092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine.
    Russell JC; Dolphin PJ; Graham SE; Amy RM; Brindley DN
    Diabetologia; 1998 Apr; 41(4):380-9. PubMed ID: 9562341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel complex of arginine-silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats.
    Proctor SD; Kelly SE; Russell JC
    Diabetologia; 2005 Sep; 48(9):1925-32. PubMed ID: 15991019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin-resistant JCR:LA-cp rat.
    Proctor SD; Kelly SE; Vine DF; Russell JC
    Metabolism; 2007 Oct; 56(10):1318-25. PubMed ID: 17884439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats.
    Naderali EK; Pickavance LC; Wilding JP; Doyle PJ; Williams G
    Eur J Pharmacol; 2001 Mar; 416(1-2):133-9. PubMed ID: 11282122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-sensitizing and cardiovascular effects of the sodium-hydrogen exchange inhibitor, cariporide, in the JCR: LA-cp rat and db/db mouse.
    Russell JC; Proctor SD; Kelly SE; Löhn M; Busch AE; Schäfer S
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):746-53. PubMed ID: 16306797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance.
    O'Brien SF; McKendrick JD; Radomski MW; Davidge ST; Russell JC
    Can J Physiol Pharmacol; 1998 Jan; 76(1):72-6. PubMed ID: 9564552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
    Mingorance C; Gonzalez del Pozo M; Dolores Herrera M; Alvarez de Sotomayor M
    Br J Nutr; 2009 Oct; 102(8):1145-53. PubMed ID: 19545458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
    McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
    Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat.
    Russell JC; Kelly SE; Schäfer S
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):258-65. PubMed ID: 15243308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats.
    Wang Y; Lu J; Ruth MR; Goruk SD; Reaney MJ; Glimm DR; Vine DF; Field CJ; Proctor SD
    J Nutr; 2008 Nov; 138(11):2117-22. PubMed ID: 18936207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum.
    Paskaloglu K; Sener G; Ayanğolu-Dülger G
    Eur J Pharmacol; 2004 Sep; 499(3):345-54. PubMed ID: 15381057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats.
    Russell JC; Kelly SE; Vine DF; Proctor SD
    Br J Pharmacol; 2009 Nov; 158(6):1588-96. PubMed ID: 19814728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.
    Madsen AN; Hansen G; Paulsen SJ; Lykkegaard K; Tang-Christensen M; Hansen HS; Levin BE; Larsen PJ; Knudsen LB; Fosgerau K; Vrang N
    J Endocrinol; 2010 Sep; 206(3):287-96. PubMed ID: 20508079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.